חזרה לתוצאות החיפוש

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Liver Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Mayo Clinic, Phoenix, Arizona, United States

    Contact: Study coordinator (Mitesh J. Borad, MD) · 855-776-0015

  • Mayo Clinic, Jacksonville, Florida, United States

    Contact: Study coordinator (Hani M. Babiker, MD) · 855-776-0015

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Richard Kim, MD)
    Contact: Study coordinator (O'Neke Nickle) · O'Neke.Nickle@moffitt.org

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Nguyen H. Tran, MD) · 855-776-0015

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Max Sung, MD) · GICancerClinicalResearch@mssm.edu

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Sunyoung Lee, MD) · GIClinicalTrials@mdanderson.org

  • The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China

  • Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Gong Li, Doctor)
    Contact: Principal Investigator (Gong Li, Doctor)

  • The Fifth Medical Center of the General Hospital of the Chinese People's Liberation Army, Beijing, Beijing Municipality, China

  • Chongqing Cancer Hospital, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Dewei Li, Doctor)
    Contact: Principal Investigator (Dewei Li, Doctor)
    Contact: Principal Investigator (Yongsheng Li, Doctor)

  • Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China

  • Sun Yat Sen Memorial Hospital, Guangzhou, Guangdong, China

  • Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi, China

  • Weifang People's Hospital, Weifang, Hebei, China

  • Harbin Medical University Cancer Hospital, Haerbin, Heilongjiang, China

    Contact: Study coordinator (Yuxian Bai, Doctor)
    Contact: Principal Investigator (Yuxian Bai, Doctor)

  • First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

  • Henan Cancer Hospital, Zhengzhou, Henan, China

  • Hubei Cancer Hospital, Wuhan, Hubei, China

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Xiaoping Chen, Doctor)
    Contact: Principal Investigator (Xiaoping Chen, Doctor)

  • Hunan Cancer Hospital, Changsha, Hunan, China

  • Hunan Provincial People's Hospital, Changsha, Hunan, China

  • Suzhou University Affiliated Second Hospital, Suzhou, Jiangsu, China

  • Tonghua Central Hospital, Tonghua, Jilin, China

  • Shengjing Hospital of China medical university, Shenyang, Liaoning, China

  • General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

  • Jinan Central Hospital, Jinan, Shandong, China

  • Linyi Cancer Hospital, Linyi, Shandong, China

  • The First Affiliated Hospital of Xi'an Jiaotong University, Xian, Shanxi, China

  • Mianyang Central Hospital, Mianyang, Sichuan, China

    Contact: Study coordinator (Xiaobo Du, Doctor)
    Contact: Principal Investigator (Xiaobo Du, Doctor)

  • Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China

  • National Cheng Kung University Hospitals, Tainan, Taiwan

  • Nation Taiwan University Hospital, Taipei, Taiwan

מובילי המחקר

  • Xiaoping Chen, Doctor

    Principal Investigator

    Tongji Hospital

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)